vaginal mesh 79 articles

Settlement talks are currently underway between manufacturers of transvaginal mesh and women who say they suffered serious complications from the defectively designed products. Attorneys for Boston Scientific, Coloplast, Cook Medical, and C.R. Bard entered into discussions to resolve the tens of thousands of lawsuits waged against them. The only manufacturer that did not join the discussion was Ethicon, a subsidiary of Johnson & Johnson. There are more than 30,000 lawsuits against the five companies that are engaged in settlement talks. However, that number is expected to grow to upwards of 50,000 as more plaintiffs join in the settlement proceedings. Transvaginal ... Read More

More than 10,000 lawsuits involving Ethicon Gynecare transvaginal mesh have been filed in the Southern District of West Virginia, all claiming the surgical mesh products were defectively designed and made, and that Ethicon failed to warn doctors and patients of the risks associated with the devices. Ethicon, a subsidiary of Johnson & Johnson, is also facing an additional 4,400 transvaginal mesh lawsuits currently pending in multi-county litigation in New Jersey’s Atlantic County Superior Court. Ethicon is just one of six manufacturers of transvaginal mesh. There are more than 30,000 transvaginal mesh lawsuits currently pending in separate proceedings in just the ... Read More

Five manufacturers of transvaginal mesh, including C.R. Bard and Boston Scientific Corp., have entered settlement talks with lawyers for plaintiffs who say the polypropylene mesh products have caused serious, often debilitating injuries, Bloomberg news reported. Together the companies face tens of thousands of personal-injury lawsuits in state and federal courts. About 30,000 complaints filed in U.S District Courts throughout the country have been consolidated for multidistrict litigation (MDL) in a Charleston, W.Va., federal court, where Judge Joseph Goodwin is overseeing the proceedings. The total number of lawsuits could swell to 50,000 as more and more women experiencing transvaginal mesh complications or ... Read More

Just minutes before a transvaginal mesh bellwether case in multidistrict litigation (MDL) was to begin, the judge announced that medical device manufacturer C.R. Bard had reached a settlement with defendants. The agreement comes less than a week after the company was ordered to pay $2 million in the first bellwether trial. The terms of the settlement are confidential, but it represents just a drop in the bucket of litigation facing the medical device company related to its Avaulta transvaginal mesh implants. The lawsuits allege the mesh, which is used to treat pelvic organ prolapse and stress urinary incontinence, caused internal injuries ... Read More

A jury in Charleston, W.V., ordered C.R. Bard to pay a Georgia nurse $2 million for severe injuries and pain she alleged she received from an Avaulta transvaginal mesh device that she had implanted in 2009 to correct a form of pelvic organ prolapse. Plaintiff Donna Cisson, 55, was the first plaintiff who filed a product-injury complaint against a transvaginal mesh manufacturer in federal court to have her case tried. Her case was the first to be tried out of more than 23,000 lawsuits against Bard and five other transvaginal mesh manufacturers that have been consolidated for multidistrict litigation (MDL) ... Read More

A C.R. Bard executive repeatedly dodged questions presented by the lead plaintiffs’ attorney in the first transvaginal mesh case to go to trial, frustrating U.S. District Judge Joseph R. Goodwin, who is overseeing the giant body of litigation in a federal West Virginia court. Plaintiff Donna Cisson, 55, filed a personal injury lawsuit against C.R. Bard, alleging its Bard Avaulta Plus Posterior BioSynthetic Support System mesh device caused extensive injuries and pain after she had it implanted in May 2009 to correct a form of pelvic organ prolapse. Her case was selected to be tried first out more than 23,000 other cases ... Read More

The first of thousands of personal-injury lawsuits filed in federal courts against six makers of transvaginal mesh devices is underway in Charleston, W.V. A lawsuit filed by plaintiff Donna Cisson, 55, against C.R. Bard was selected as the first of more than 27,000 cases consolidated for multidistrict litigation (MDL) in a West Virginia federal court to be heard. Ms. Cisson’s lawsuit is one of more than 4,000 that manufacturer C.R. Bard faces. Other manufacturers of transvaginal mesh in the MDL include Boston Scientific, Cook Medical Inc., Coloplast Corp, and Ethicon (a unit of Johnson & Johnson). Ms. Cisson was implanted ... Read More

Product liability lawsuits filed against manufacturers of transvaginal mesh products are mounting ahead of an approaching two-year statute of limitations in several states. Six medical device makers – Boston Scientific, Coloplast, C.R. Bard, Ethicon/Johnson& Johnson, and Cook Medical Systems – are among the medical device makers who collectively face about 16,000 lawsuits filed by women and their families. The lawsuits blame transvaginal mesh products, used to correct pelvic organ prolapse (POP) and urinary incontinence, for serious and often debilitating injuries. Many plaintiffs allege that the polypropylene devices eroded through the vaginal wall, perforated organs, caused vaginal scarring and shrinkage, bleeding, infection ... Read More

Claims against Cook Medical, Inc. and its vaginal mesh products may soon join lawsuits consolidated in the Southern District of West Virginia. The cases currently involve transvaginal mesh devices made by companies including Boston Scientific, Coloplast, Ethicon (Johnson & Johnson), and C.R. Bard. Transvaginal mesh is a type of surgical mesh that is used to repair pelvic floor disorders such as pelvic organ prolapse and stress urinary incontinence. It is implanted through the vagina to hold up organs that have dropped, or prolapsed, causing symptoms such as pain, discomfort, incontinence, and painful sexual intercourse. The Food and Drug Administration (FDA) has ... Read More

The findings of a new transvaginal mesh safety study published May 15 in the Journal of the American Medical Association (JAMA) support previous studies and U.S. Food and Drug Administration (FDA) warnings that mesh devices used to correct pelvic organ prolapse (POP) pose a higher risk of injury than conventional surgical repairs. The study’s authors also say that the medical community knows little about the special safety risks and long-term effectiveness of the devices, even though more than 225,000 women are implanted with them every year in the United States. The statement underscores the claim of many plaintiffs and other ... Read More